NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000000790

Registered date:07/11/2007

The Heart Institute of Japan Candesartan Randomized trial for Evaluation in Coronary Artery Disease

Basic Information

Recruitment status Complete: follow-up complete
Health condition(s) or Problem(s) studiedCoronary artery disease
Date of first enrollment2001/06/01
Target sample size2030
Countries of recruitmentJapan
Study typeInterventional
Intervention(s)Candesartan-based therapy without any angiotensin-converting enzyme inhibitors Non-ARB based standard therapy

Outcome(s)

Primary OutcomeThe primary endpoint of the present study was the time to the first major adverse cardiovascular events.
Secondary OutcomeThe major secondary endpoints included the incidence of coronary revascularization and new-onset diabetes.

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximum80years-old
GenderMale and Female
Include criteriaCoronary angiographically documented patients with coronary artery disease and hypertension
Exclude criteriaPatients with socondary hypertension hypertrophic obstructive cardiomyopathy Acute myocardial infarction (withih 7 days) cerebrovascular disease within 3 months serum Creatinine >=2.0mg/dl hyperkalemia

Related Information

Contact

public contact
Name Hiroshi Ogawa
Address 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan Japan
Telephone 03-3353-8111
E-mail mogawa@hij.twmu.ac.jp
Affiliation The Heart Institute of Japan, Tokyo Women's Medical University Cardiology
scientific contact
Name Hiroshi Kasanuki
Address 8-1 Kawada-cho, Shinjuku-ku, Tokyo 162-8666, Japan Japan
Telephone 03-3353-8111
E-mail
Affiliation The Heart Institute of Japan, Tokyo Women's Medical University Cardiology